If appropriate, you may begin your first dose the same day
To view a copy of this license, visit About this article Cite this article Gulyaeva, N.V
Retatrutide has neither
Consult your healthcare provider first if you're pregnant, nursing, immunocompromised, or managing an existing digestive condition
Last reviewed: June 29, 2026 Last updated: June 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
January 2026: Strong pipeline activity was observed in oral anti-diabetic drugs, with increased focus on SGLT2 inhibitors and combination therapies aimed at reducing cardiovascular risks in diabetic patients